Search for:
Home
What Differentiates 20/20 HCP
Team
Portfolio
Portfolio
Exits
News
Contact
SQZ Biotech
Novel Cell engineering Platform from MIT/Langer Labs
Delivers DNA, RNA, Proteins, CRISPR Tx, Small Molecules
State of the Art Therapies for Immuno-oncology
Works with Patient’s own Immune System
IPO NYSE (SQZ)
< All Exits